Показано 0 из 0
Дата |
---|
19:38 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.89
|
2.045
|
1.994
|
1.994
|
1.994
|
1.994
|
|
|
|
|
2.01
|
2.185
|
1.994
|
1.994
|
1.994
|
1.994
|
|
|
|
|
2.01
|
2.145
|
1.904
|
1.904
|
1.904
|
1.904
|
|
|
|
|
1.884
|
2.01
|
1.904
|
1.904
|
1.904
|
1.904
|
|
|
|
|
1.806
|
1.952
|
1.904
|
1.904
|
1.904
|
1.904
|
|
|
|
|
1.81
|
1.946
|
1.904
|
1.904
|
1.904
|
1.904
|
|
|
|
|
1.838
|
1.966
|
1.904
|
1.904
|
1.904
|
1.904
|
|
|
|
|
1.80
|
1.946
|
1.936
|
1.936
|
1.936
|
1.936
|
|
|
|
|
1.818
|
1.964
|
1.94
|
1.94
|
1.94
|
1.94
|
|
|
|
|
1.884
|
2.02
|
1.648
|
1.648
|
1.648
|
1.648
|
|
|
|
|
Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.